← Back to catalogue

Ihc

FDA UDI

Class I (US FDA UDI)

by Slmp, LLC

Identity

Trade Name
IHC FDA UDI
Generic Name
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI
Device Name
PMS2, Clone A16-4/Clone EP51, 6mL (Manual) FDA UDI
Model / Reference
(BTO) Manual RTU PMS2 (A16-4) Antibody (6ml) FDA UDI
Description
PMS2, Clone A16-4/Clone EP51, 6mL (Manual) FDA UDI

Identifiers

Catalog Number
MM127-6 FDA UDI
Primary DI / UDI-DI
00810170550553 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Postmeiotic segregation increased 2 (PMS2) IVD, antibody

Ihc by Slmp, LLC — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Postmeiotic segregation increased 2 (PMS2) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Slmp, LLC

Sources (1)

  • FDA UDI 4cc92c65-4c33-48c3-bbca-cd49249f42a0 34 fields · synced May 30, 2026